Global Economic Slowdown/Uncertainty: Middle East conflict driving oil prices higher and IMF downgrading global growth forecasts could lead to decreased investor confidence, impacting growth sectors like biotech and potentially affecting healthcare spending indirectly.

Inflationary Pressures: Rising oil prices contribute to inflation, which may increase operating costs for biopharmaceutical companies (e.g., manufacturing, distribution) and could prompt central banks to maintain higher interest rates, affecting the cost of capital.

Strong US Labor Market: A robust US economy, evidenced by job additions and low unemployment, could support consumer spending and demand for healthcare products. However, it might also contribute to wage inflation and potential further interest rate hikes.